Same diagnosis. Same treatment. One gets better — one doesn't. The difference isn't the drug. It's whether your doctor truly ...

Introduction The underlying causes of supply-side and demand-side challenges in immunisation are poorly understood, leading to symptomatic solutions. This study engaged stakeholders to develop ...

US benchmarking of drug prices against foreign markets could have unintended consequences, says Czech health economist Tomáš ...

Background Patients with heart failure (HF) frequently suffer from undetected declines in cardiorespiratory fitness (CRF), which significantly increases their risk of poor outcomes. However, current ...

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou ...

New research co-led by Burnet Institute and WEHI has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of ...

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

Models that provide hybrid payments to primary care practices without adding financial risk are effective at supporting the ...

Partner program empowers advisors, consultants, and technology partners to work together under a global framework built ...

Globally, an estimated 300 million people live with a rare disease. They typically experience isolation, diagnostic difficulties, lack of therapies, fragmented care, stigma, a struggle for recognition ...